NIBRT Hosts Groundbreaking Medicines of the Future Biopharma Manufacturing Conference

NIBRT Hosts Groundbreaking Medicines of the Future Biopharma Manufacturing Conference

Friday 24 May 2024: Dublin, Ireland:  – The National Institute for Bioprocessing Research and Training (NIBRT) today Friday 24th May, hosts Medicines of the Future Conference, a landmark event, bringing together experts, researchers, and industry professionals to explore the latest advancements, challenges, and opportunities in the development and manufacture of advanced therapeutics.

The conference presents a prime opportunity to highlight Ireland’s flourishing biopharma research ecosystem and enhance the country’s reputation as a leading hub of innovation and expertise in biopharma manufacturing. The conference is attended today by over 100 delegates from across academia and industry.
 
Throughout the day, attendees will engage with internationally recognised academic and industry experts and distinguished speakers present, including Professor Dame Sarah Gilbert DBE FRS, Saïd Professor of Vaccinology, University of Oxford, Professor Nicki Panoskaltsis, Professor in Personalised Therapeutics, School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin and St. James’s Hospital, Dr. Bernie Sweeney, Head of the Cell Expression Centre of Excellence, BioR&D Lonza and Dr. Larry Bacon, Consultant Haematologist, St James Hospital. The event will also be livestreamed allowing delegates from around the world to view online over the course of the day.

Topics that will be covered at the conference include the development and manufacture of cell therapies, vaccine manufacture, translation & acceptance, cell expression systems and processes used to manufacture advanced biotherapeutics and the development and manufacture of protein-based therapies / multispecific therapies.
 
During the conference, NIBRT will also introduce attendees to the new CONCEPT facility. CONCEPT – A core facility for early-stage biotherapy development forms part of the new Cell and Gene Therapy building at NIBRT, funded by IDA Ireland. Central to the operation of this facility are state-of-the-art instrumentation funded by Science Foundation Ireland (SFI).

Speaking at the conference today Professor Dame Sarah Gilbert commented ‘’”It has been a pleasure to be here today at Medicines of the Future. I thoroughly enjoyed touring the facilities and learning more about the capabilities at NIBRT.”

“We are incredibly proud of the success of the Medicines of the Future Conference,” said Dr Fiona Killard-Lynch, NIBRT Director of Research and Innovation “The high level of engagement and the quality of discussions have been outstanding, and it’s clear that with the development of new therapeutic approaches our industry is poised for remarkable advancements. This conference has laid the groundwork for future innovations that will transform biopharma manufacturing.”
 

-ENDS-

(Pictured; (left to right), Professor Nicki Panoskaltsis, Trinity College Dublin and St. James’s Hospital, Dr Fiona Killard-Lynch, NIBRT, Professor Dame Sarah Gilbert DBE FRS, University of Oxford, Dr. Larry Bacon, St James Hospital, Dr. Bernie Sweeney, Lonza